Carrie Smith Cox
CIK: 0001110753
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- May 15, 2026SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
4.8K shares- - May 13, 2026TXN
TEXAS INSTRUMENTS INC
Sale(S)Direct8.4K shares at avg. $306.37$2.6M - May 13, 2026TXN
TEXAS INSTRUMENTS INC
Exercise(M)Direct4.3K shares at avg. $110.15$474K - May 13, 2026TXN
TEXAS INSTRUMENTS INC
Exercise(M)Direct4.5K shares at avg. $104.41$473K - May 13, 2026TXN
TEXAS INSTRUMENTS INC
Sale(S)Direct445 shares at avg. $307.04$137K - Apr 30, 2026SOLV
Solventum Corp
Exercise(M)Direct4.9K shares- - Mar 27, 2026SOLV
Solventum Corp
Exercise(M)Direct6.3K shares- - Jan 29, 2026TXN
TEXAS INSTRUMENTS INC
Award(A)Direct525 shares- - Nov 12, 2025OGN
Organon & Co.
Purchase(P)Indirect65.4K shares at avg. $7.67$502K - Jun 13, 2025OGN
Organon & Co.
Award(A)DirectPhantom Stock
23.9K shares at avg. $10.04- - May 14, 2025OGN
Organon & Co.
Purchase(P)Direct12.5K shares at avg. $8.07$101K - May 13, 2025SOLV
Solventum Corp
Exercise(M)Direct5.1K shares- - Apr 30, 2025SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
4.9K shares- - Jan 27, 2025TXN
TEXAS INSTRUMENTS INC
Award(A)Direct614 shares- - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
Award(A)Direct2.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 |  SOLV Solventum Corp | Award(A) Restricted Stock Units | 4,848 | - | - | Direct |
| May 13, 2026 |  TXN TEXAS INSTRUMENTS INC | Sale(S) | 8,393 | $306.37 | $2,571,394 | Direct |
| May 13, 2026 | TXN TEXAS INSTRUMENTS INC | Exercise(M) | 4,306 | $110.15 | $474,306 | Direct |
| May 13, 2026 | TXN TEXAS INSTRUMENTS INC | Exercise(M) | 4,532 | $104.41 | $473,186 | Direct |
| May 13, 2026 | TXN TEXAS INSTRUMENTS INC | Sale(S) | 445 | $307.04 | $136,634 | Direct |
| Apr 30, 2026 | SOLV Solventum Corp | Exercise(M) | 4,916 | - | $0 | Direct |
| Mar 27, 2026 | SOLV Solventum Corp | Exercise(M) | 6,336 | - | $0 | Direct |
| Jan 29, 2026 | TXN TEXAS INSTRUMENTS INC | Award(A) | 525 | - | $0 | Direct |
| Nov 12, 2025 |  OGN Organon & Co. | Purchase(P) | 65,400 | $7.67 | $501,755 | Indirect |
| Jun 13, 2025 | OGN Organon & Co. | Award(A) Phantom Stock | 23,904 | $10.04 | - | Direct |
| May 14, 2025 | OGN Organon & Co. | Purchase(P) | 12,469 | $8.07 | $100,591 | Direct |
| May 13, 2025 | SOLV Solventum Corp | Exercise(M) | 5,148 | - | - | Direct |
| Apr 30, 2025 | SOLV Solventum Corp | Award(A) Restricted Stock Units | 4,916 | - | - | Direct |
| Jan 27, 2025 | TXN TEXAS INSTRUMENTS INC | Award(A) | 614 | - | $0 | Direct |
| Jan 2, 2025 |  RNAC Cartesian Therapeutics, Inc. | Award(A) | 2,600 | - | $0 | Direct |
1-15 of 15 transactions
About COX CARRIE SMITH
COX CARRIE SMITH (SEC CIK 0001110753) files insider reports with the SEC as Director of Solventum Corp (SOLV), Director of TEXAS INSTRUMENTS INC (TXN) and Director of Organon & Co. (OGN). Signal8 also holds filings tied to 1 other company.
Signal8 holds 12 ownership filings by COX CARRIE SMITH, all Form 4s, filed between Jan 6, 2025 and May 18, 2026. Those filings report 15 transactions, from Jan 2, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on COX CARRIE SMITH's filings is in EAGAN, MN.
Recent filings by COX CARRIE SMITH
- May 15, 2026: Grant or award of SOLV derivative securities (Form 4, code A).
- May 13, 2026: Open-market sale of TXN shares (Form 4, code S).
- May 13, 2026: Option exercises of TXN shares (2 lines, Form 4, code M).
- May 13, 2026: Open-market sale of TXN shares (Form 4, code S).
- Apr 30, 2026: Option exercise of SOLV shares (Form 4, code M).
Other insiders filing for Solventum Corp (SOLV)
- Hanson Bryan C, Chief Executive Officer
- Zieselman Neil Craig, SVP, Controller & CAO
- ALBAN CARLOS, Director
- DeVore Susan D., Director
- Edwards Shirley Ann, Director
- EISENBERG GLENN A, Director